|
Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for qualified medical advice, visits or professional assistance by using a real mD. We are not docs. Always confer with your physician about Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy Clinical research trials and Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy health trials occur in many of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectivity of new does drugs. The intent of the studies / undertakings is to resolve particular human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to detect remedies for all sorts of conditions, including Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy. Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy Clinical Trials and other clinical trials permit volunteers to obtain healthcare treatment alternatives before they are available to the masses. Most times the participants undergo professional assistance for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy clinical trial. Test subjects typically receive the most expert healthcare available for their Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy condition. Dangers are a reality, however, and may include more or frequent mD visits, healthcare dangers (perhaps life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy  Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy
Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy
For Condition: HIV Infections,Pain,Peripheral Nervous System Diseases
Status: Recruiting
Sponsor(s): NeurogesX ,
Synopsis: The purpose of the study is to determine if an investigational drug, NGX-4010 (high-concentration capsaicin patch), is effective in treating painful HIV-associated neuropathy.
Details: The C107 study is a randomized, double-blind, controlled dose finding study of NGX-4010 for the treatment of painful symptoms of HIV-associated neuropathy. Participants will be randomly assigned to receive initial treatment according to one of three doses (application durations), and to receive double-blind NGX-4010 patch (high-concentration capsaicin) or matching control (low-concentration capsaicin). Participants who complete study evaluations through Week 12 will have the option of receiving up to 3 additional open-label treatments.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Dose Comparison, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Key Eligibility Criteria: • Must have had HIV-associated neuropathy for at least 2 months, with moderate to severe pain in both feet. • Must not have significant pain in feet due to other causes (for example, arthritis). • Must have intact skin at the treatment area. • Must be prepared to remain on the same pain medications at the same doses as before the study for the entire duration of the study (one year). • Must not use topical pain medications for HIV-associated neuropathy. • Must be able to comply with study requirements such as completing daily pain diary and attending study visits and refrain from extensive travel during study participation. • Must be at least 18 years old, not pregnant, and able to take care of self independently, with only occasional assistance if needed. • No significant medical problems of the heart, kidneys, liver or lungs, or cancer. • No history or current problem with substance abuse.
Total Enrollment: 300
Location and Contact Information:
Neurology Clinical Research *Recruiting*
Plantation, Florida, 33324
United States
Recruiting Francisco Torres 954-475-8171
East Bay AIDS Center *Recruiting*
Berkeley, California, 94705
United States
Recruiting Jamie Mandelke 510-204-1291
Park Nicollet Health Clinic *Recruiting*
Minneapolis, Minnesota, 55416
United States
Recruiting Meaghan Morton 952-993-2066
Community Research Initiative of New England *Recruiting*
Boston, Massachusetts, 02215
United States
Recruiting Karlissa Foy 617-778-5454
Steinhart Medical Center *Recruiting*
Miami, Florida, 33133
United States
Recruiting Amy Leibmann 305-856-2171
University of Kentucky *Recruiting*
Lexington, Kentucky, 40536
United States
Recruiting Yunanan Mootoor 859-323-6702
Body Positive *Recruiting*
Phoenix, Arizona, 85006
United States
Recruiting Gilda Garza 602-307-5330
University of North Carolina at Chapel Hill *Recruiting*
Chapel Hill, North Carolina, 27599
United States
Recruiting Wendy Robertson 919-966-6727
Stanford University Medical Center *Recruiting*
Stanford, California, 94305
United States
Recruiting Alexandria Luc 650-724-3792
University of Miami School of Medicine *Recruiting*
Miami, Florida, 33136
United States
Recruiting Leslie Thompson 305-243-3838
Central Texas Clinical Research *Recruiting*
Austin, Texas, 78705
United States
Recruiting Corey King 512-480-9660
Mount Sinai School of Medicine, Department of Neurology *Recruiting*
New York City, New York, 10029
United States
Recruiting Mary George 212-241-0784
First Clinical Research *Recruiting*
San Francisco, California, 94117
United States
Recruiting Lonnie Leonard 415-682-2434
AIDS Research Alliance *Recruiting*
West Hollywood, California, 90069
United States
Recruiting Michele Vertucci 310-358-2429
Albany Medical Center *Recruiting*
Albany, New York, 12208
United States
Recruiting Cynthia Morvillo 518-262-6970
University of Wisconsin *Recruiting*
Madison, Wisconsin, 53792-5132
United States
Recruiting Joanne Lubich 608-263-4290
HACRP - University of Hawaii *Recruiting*
Honolulu, Hawaii, 96816
United States
Recruiting Nancy Hanks 808-441-1531
The Cooper Health System *Recruiting*
Camden, New Jersey, 08103-1489
United States
Recruiting Alex Marr 856-968-7331
Case Western Reserve *Recruiting*
Cleveland, Ohio, 44106
United States
Recruiting Ron Johnson 216-844-3246
Community Research Initiative of New England *Recruiting*
Springfield, Massachusetts, 01107
United States
Recruiting Laurie Wojtusik 413-734-2264
Cook County Hospital, Dept. of Neurological Sciences *Recruiting*
Chicago, Illinois, 60612
United States
Recruiting Eileen Simeone 312-572-4578
University of California, San Diego *Recruiting*
San Diego, California, 92103
United States
Recruiting Will Toperoff 619-543-4734
Johns Hopkins University *Recruiting*
Baltimore, Maryland, 21205
United States
Recruiting Kathryn Carter 410-955-1895
Integra Clinical Research, LLC *Recruiting*
San Antonio, Texas, 78229
United States
Recruiting Cathy Kirkland 210-692-9249
The Research and Education Group *Recruiting*
Portland, Oregon, 97209
United States
Recruiting Erin Merrifield 503-229-8428
Wayne State University *Recruiting*
Detroit, Michigan, 48201
United States
Recruiting Kelly Jia 313-966-9407
IDC Research Initiative *Recruiting*
Altamonte Springs, Florida, 32071
United States
Recruiting Charmaine Stiles 407-647-3960
Treasure Coast Infectious Disease Consultants *Recruiting*
Vero Beach, Florida, 32960
United States
Recruiting Jeff Mieres 772-978-9556
New York Presbyterian Hospital *Recruiting*
New York City, New York, 10021
United States
Recruiting Ivanka Zaprlanov 212-746-2349
Arizona Clinical Research *Recruiting*
Phoenix, Arizona, 85023
United States
Recruiting Dawn Allen 602-863-6363
Washington University School of Medicine *Recruiting*
St. Louis, Missouri, 63108
United States
Recruiting Mary Gould 314-362-9733
North Dallas Center for AIDS & Clinical Research *Recruiting*
Dallas, Texas, 75208
United States
Recruiting John Gonzalez 214-941-4000
Infectious Disease of the Palm Beaches Associates *Recruiting*
North, Florida, 33408
United States
Recruiting Dora Vasquez 561-630-1402
Additional Information:
Study ID Numbers: C107;
Study Start Date:
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00064623
Other Pain Studies:
1. A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection
2. A Study to Evaluate the Use of Memantine In Combination with Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)
3. Ganciclovir Implant Study for Cytomegalovirus Retinitis
4. A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy
5. Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients with AIDS Who Have CMV Retinitis
Related Studies:
Other Pain Clinical Trials
Other California Clinical Trials
Other West Hollywood Clinical Trials
Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy
|
|
|
|
|
|
|
|
